Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print New Study on Effects of Disclosing Financial Interests on Participation in Medical Research

New Study on Effects of Disclosing Financial Interests on Participation in Medical Research

October 06, 2008

Baltimore, MD. - Knowing how an investigator is paid for running a research study surprisingly plays a small role in patients' willingness to take part in clinical trials. However, according to a new Johns Hopkins University study more participants are troubled when they are told that the investigator could profit or lose money depending on the results.

In an effort to learn more about the effects of disclosing an investigator's financial interests on potential study participants, researchers from the Johns Hopkins Berman Institute of Bioethics, Duke University Medical Center, and Wake Forest University surveyed 470 patients from an outpatient cardiology clinic. Each of these patients, who were diagnosed with coronary artery disease, agreed to go through a consent process over the phone for a hypothetical clinical trial.




The study, published in the October issue of the American Heart Journal, found that simply revealing an investigator's financial interest in a study does little to affect the patient's decisions to enroll in a hypothetical clinical trial. What the study did find was that patients were more concerned about certain types of financial interests, especially when the investigator owned stock in the company financing the study.

"Disclosure of investigators' financial interests in research does not substantially affect a person's willingness to participate," says Jeremy Sugarman, M.D., senior author of the study and Harvey M. Meyerhoff Professor of Bioethics and Medicine at the Johns Hopkins Berman Institute of Bioethics, however, "ethically it's important that the patient's 'right to know' is respected before they consent to enroll in research."

"What seems to be important in the decision-making process was the patients' pre-existing level of trust in medical research in general," says Dr. Kevin Weinfurt, a medical psychologist at Duke and the lead author of the study.

The team of researchers first assessed the patients' overall level of trust in medical research. Investigators then randomly assigned them to one of three disclosure groups: Members of one group were told the clinic involved in the study would receive per capita payments per enrollee that would be used to cover the costs of the trial, including the doctor's salary. Participants in a second group were told that the investigator held stock in the company sponsoring the research. There were no disclosure statements made to members of the third group.

When asked how likely they would be to join a clinical trial, members of all three groups expressed a moderate degree of willingness to do so. Still, there were some important differences between the groups.

Patients who heard about stock ownership were less willing than those in the other two groups to indicate that they would participate in the study. In addition, they spontaneously offered three times the number of negative comments about the relationship than participants in the other groups, using words like, "disingenuous," "unacceptable," and "unethical." In addition, ten members of the group that were told about stock ownership in the company sponsoring the trial, spontaneously said they would not take part in the trial compared with only one such comment from the other two groups.

In general, members of the per capita group felt that a financial arrangement that helped cover costs of the trial was acceptable, saying, "OK, that sounds more appropriate. So there's no payment to him, but through the university. OK, I'm good."

But some members in the group that was told about stock ownership found positive things to say about that arrangement, too. One person volunteered that "It looks like he'd have this real incentive for this thing to go real well, and I guess that's all to the good."

"The findings of this study make it clear that policy makers need to continue to address the issue of conflicts of interest in research conducted by investigators who stand to profit from the results of clinical trials," says Sugarman. When it comes to financial disclosure between investigators and research participants Sugarman says, "Policy makers may want to consider more restrictive policies for equity relationships than for other financial interests in research."

It's important to note that participants in the study were disproportionately middle-to higher income white men, and the researchers say lower income participants from other racial groups might feel differently about financial relationships between researchers and sponsoring companies.

The study was funded by a grant from the National Heart, Lung, and Blood Institute.

Other researchers involved in the study include Joelle Friedman, Chantelle Hardy, Alice Fortune-Greely, Janice Lawlor, Jennifer Allsbrook, Li Lin and Kevin Schulman, of Duke, and Mark Hall, from Wake Forest University.

Johns Hopkins Berman Institute of Bioethics



Related Medical Research Current Events and Medical Research News Articles Medical Research Current Events and Medical Research News RSS Medical Research Current Events and Medical Research News RSS
Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation
A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation.

OMRF scientists discover promising new path for treating traumas
A discovery by scientists at the Oklahoma Medical Research Foundation could help save lives threatened by traumatic injuries like those sustained in car crashes or on the battlefield. The work also holds potential for treating severe infectious diseases and diabetes.

Fetal study highlights impact of stress on male fertility
Exposure to a combination of excess stress hormones and chemicals while in the womb could affect a man's fertility in later life, a study suggests.

Time in a bottle: Scientists watch evolution unfold
A 21-year Michigan State University experiment that distills the essence of evolution in laboratory flasks not only demonstrates natural selection at work, but could lead to biotechnology and medical research advances, researchers said.

Research shows treating HIV-AIDS with interleukin-2 is ineffective
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.

Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.

Whale-sized genetic study largest ever for southern hemisphere humpbacks
After 15 years of research in the waters of the South Atlantic and Indian Oceans, scientists from the Wildlife Conservation Society, the American Museum of Natural History, and an international coalition of organizations have unveiled the largest genetic study of humpback whale populations ever conducted in the Southern Hemisphere.

Packages of care for epilepsy in low- and middle-income countries
In the second in a six part series on treating mental health problems in resource-poor settings, Caroline Mbuba and Charles Newton (Centre for Geographic Medicine Research, Kenya Medical Research Institute, Kilifi, Kenya) discuss "packages of care" for treating epilepsy.

UCSD researchers pave the way for effective liver treatments
A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.
More Medical Research Current Events and Medical Research News Articles
Research Methodology in the Medical and Biological Sciences

Research Methodology in the Medical and Biological Sciences
by Petter Laake (Author), Haakon Breien Benestad (Author), Bjorn Reino Olsen (Editor)

Providing easy-to-access information, this unique sourcebook covers the wide range of topics that a researcher must be familiar with in order to become a successful experimental scientist. Perfect for aspiring as well as practicing professionals in the medical and biological sciences it discusses a broad range of topics that are common, yet not traditionally considered part of formal curricula. The information presented also facilitates communication across conventional disciplinary boundaries, in line with the increasingly multidisciplinary nature of modern research projects.

· Perfect for students with various professional backgrounds providing a broad scientific perspective
· Easily accessible, concise material makes learning about...

Medical Statistics from Scratch (Bowers, Medical Statistics from Scratch: An Introduction for Health Professionals)

Medical Statistics from Scratch (Bowers, Medical Statistics from Scratch: An Introduction for Health Professionals)
by David Bowers (Author)

This long awaited second edition of this bestseller continues to provide a comprehensive, user friendly, down-to-earth guide to elementary statistics. The book presents a detailed account of the most important procedures for the analysis of data, from the calculation of simple proportions, to a variety of statistical tests, and the use of regression models for modeling of clinical outcomes.

The level of mathematics is kept to a minimum to make the material easily accessible to the novice, and a multitude of illustrative cases are included in every chapter, drawn from the current research literature. The new edition has been completely revised and updated and includes new chapters on basic quantitative methods, measuring survival, measurement scales, diagnostic testing,...

The Design of Studies for Medical Research

The Design of Studies for Medical Research
by David Machin (Author), Michael J. Campbell (Author)

The same careful rigour imposed on the design of phase III randomised controlled trials is not always applied to medical research in other areas such as trials conducted at earlier stages of drug development. 

With the emphasis that is now placed on evidence-based medicine, such care and rigour will inevitably impact on these areas with increasing attention turned to the quality of design. 

This title describes what principles can be used to structure research effectively allowing for the required degree of accuracy.

Written by two best selling authors, this book includes many examples from medical literature and will be of great value to all groups conducting studies at the interface of clinical and laboratory research.



  Medical Research Council Annual Report - UK
by Medical Research Council

Contains details of MRC activities and achievements in research, partnerships with other organizations, training and career development, knowledge transfer, and public engagement.

ABC News 20/20 Almost Human-Medical research and Chimpanzees

ABC News 20/20 Almost Human-Medical research and Chimpanzees

They are innocent captives taken from their homes, nurtured by us, even taught our language then sacrificed as living experiments. Do we have a right to use chimpanzees in scientific research?Airdate: 8/2/1996

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Super Booster Softgels 60 Softgels with Advanced K2 Complex From the Life Extension Foundation. LEF Has a 27 Year History of Introducing Life Saving Medical Discoveries and Funding Scientific Research.

Super Booster Softgels 60 Softgels with Advanced K2 Complex From the Life Extension Foundation. LEF Has a 27 Year History of Introducing Life Saving Medical Discoveries and Funding Scientific Research.
by Life Extension Foundation

Ginkgo - The most popular flavonoid supplement is Ginkgo biloba. Hundreds of studies substantiate its multifaceted effects in the promotion of healthy circulatory and neurologic functions. Chlorophyllin - The pigment chlorophyllin is vividly seen in green vegetables. Scientific studies indicate that chlorophyllin may be the most potent nutrient to protect against environmental DNA damage. Selenium - The FDA states that some scientific evidence suggests consumption of selenium may reduce the risk of certain forms of cancer. However, the FDA has determined this evidence is limited and not conclusive. The ability of selenium to boost glutathione is well established, but most people don't know that there are several different forms of selenium that provide diverse biological benefits.

Non-Clinical Medical Jobs, Careers, and Opportunities

Non-Clinical Medical Jobs, Careers, and Opportunities
by Joseph Kim, MD, MPH

For physicians and other healthcare professionals who wish to learn about non-clinical medical opportunities ranging from medical writing, healthcare administration, public health, consulting, health information technology, managed care, pharma/biotech, medical education, market research, finance, venture capital, and more.Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day.

  Merriam Webster Medical Desk Dictionary
by JC Research

A Comprehensive and easy-to-use guide to the language of Medicine. Information on: AIDS biochemistry psychiatry and geriatic medicine.System Requirements:PC Pentium or equivalent CD-ROM drive (2x or faster) 640x480 VGA (SVGA 256 colors recommended) Mouse & Sound Card Speakers 4 MB 75 MB Hard DriveFormat: WIN 9598MENT2000XP/MAC 8.1-9.X (CLASSIC)X10 Genre: REFERENCE / LIFESTYLE Rating:  UPC: 798694895629 Manufacturer No: 95629

Eleotin Mb (Metabolism) Capsules

Eleotin Mb (Metabolism) Capsules
by Eastwood Bio-Medical Research, Inc.

Eleotin® improves the general health of the whole body. It is made from dried roots, stems, fruits, and leaves, from various plants. The herbal plants are all registered with pharmacopoeias and food codes in several countries. All of the material used is 100% natural without any fillers or preservatives. Eleotin® had started as a safe diabetes product, but soon many experts started to notice the safety of the Eleotin® technology, and recommended it to be applied to the weight loss programs. After all, the control of blood glucose is intimately related to the weight control issue. Recommended by Kevin Trudeau in The Weight Loss Cure. Eleotin Gold is recommended for Diabetes.

NOVA - Cracking the Code of Life

NOVA - Cracking the Code of Life
Starring: Robert Krulwich
Directed By: Betsey Arledge; Elizabeth Arledge

Does it amaze you that yeast is your very close relative? That you possess roughly the same number of genes as a mouse? That you are 99.9% genetically identical to every other human? ABC Nightline correspondent Robert Krulwich lends a lighthearted touch to genetic science in this provocative two-hour NOVA special that takes you inside the amazing, complex and contentious race to decode the human genome.

The Human Genome Project was born in 1990, when an international consortium of labs set out to sequence all 3 billion letters of our DNA, predicting they’d finish by 2005. Halfway through their schedule, controversial scientist and entrepreneur J. Craig Venter threw the genome world into turmoil, when he announced his for-profit company Celera could finish the job in just two years....

© 2009 BrightSurf.com